Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Marcaine Posterior Capsular Injection for Pain After ACL Reconstruction
NCT02826551Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Jan 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of bupivacaine in postoperative pain, sponsored by Cedars-Sinai Medical Center. Primary endpoint: Visual Analog Scale at Day 4. Started Jan 2017; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02826551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02826551.